Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR

[1] Salzer HJF(2018)Clinical, diagnostic, and treatment disparities between HIV-Infected and Non-HIV-Infected immunocompromised patients with Pneumocystis Jirovecii Pneumonia Respir Int Rev Thorac Dis 96 52-65

[2] Schäfer G(2020)Pneumocystis Jiroveci Semin Respir Crit Care Med 41 141-57

[3] Hoenigl M(2016)Short communication: diagnosis of Pneumocystis Jirovecii Pneumonia by detection of DNA in blood and Oropharyngeal Wash, compared with Sputum AIDS Res Hum Retroviruses 32 463-6

[4] Günther G(2019)Pneumocystis Jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice Clin Transplant 33 e13587-6

[5] Hoffmann C(2008)Use of a serum (1–>3)-beta-D-glucan assay for diagnosis and follow-up of Pneumocystis Jiroveci Pneumonia Clin Infect Diseases: Official Publication Infect Dis Soc Am 47 1364-9

[6] Kalsdorf B(2019)Clinical performance of (1,3) Beta-D glucan for the diagnosis of Pneumocystis Pneumonia (PCP) in Cancer patients tested with PCP polymerase chain reaction Clin Infect Diseases: Official Publication Infect Dis Soc Am 69 1303-s20

[7] Fishman JA(2021)Pneumocystis Jirovecii Disease: basis for the revised EORTC/MSGERC invasive fungal Disease definitions in individuals without human immunodeficiency virus. Clinical infectious Diseases: an official publication Infect Dis Soc Am 72 114-44

[8] van Halsema C(2011)Pneumocystis Jirovecii Pneumonia in non-HIV-infected patients: new risks and diagnostic tools Curr Opin Infect Dis 24 534-7

[9] Johnson L(2008)Epidemiology and clinical significance of pneumocystis colonization J Infect Dis 197 10-61

[10] Baxter J(2001)Search for primary Infection by Pneumocystis carinii in a cohort of normal, healthy infants Clin Infect Diseases: Official Publication Infect Dis Soc Am 32 855-2

[1] Salzer HJF(2018)Clinical, diagnostic, and treatment disparities between HIV-Infected and Non-HIV-Infected immunocompromised patients with Pneumocystis Jirovecii Pneumonia Respir Int Rev Thorac Dis 96 52-65

[2] Schäfer G(2020)Pneumocystis Jiroveci Semin Respir Crit Care Med 41 141-57

[3] Hoenigl M(2016)Short communication: diagnosis of Pneumocystis Jirovecii Pneumonia by detection of DNA in blood and Oropharyngeal Wash, compared with Sputum AIDS Res Hum Retroviruses 32 463-6

[4] Günther G(2019)Pneumocystis Jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice Clin Transplant 33 e13587-6

[5] Hoffmann C(2008)Use of a serum (1–>3)-beta-D-glucan assay for diagnosis and follow-up of Pneumocystis Jiroveci Pneumonia Clin Infect Diseases: Official Publication Infect Dis Soc Am 47 1364-9

[6] Kalsdorf B(2019)Clinical performance of (1,3) Beta-D glucan for the diagnosis of Pneumocystis Pneumonia (PCP) in Cancer patients tested with PCP polymerase chain reaction Clin Infect Diseases: Official Publication Infect Dis Soc Am 69 1303-s20

[7] Fishman JA(2021)Pneumocystis Jirovecii Disease: basis for the revised EORTC/MSGERC invasive fungal Disease definitions in individuals without human immunodeficiency virus. Clinical infectious Diseases: an official publication Infect Dis Soc Am 72 114-44

[8] van Halsema C(2011)Pneumocystis Jirovecii Pneumonia in non-HIV-infected patients: new risks and diagnostic tools Curr Opin Infect Dis 24 534-7

[9] Johnson L(2008)Epidemiology and clinical significance of pneumocystis colonization J Infect Dis 197 10-61

[10] Baxter J(2001)Search for primary Infection by Pneumocystis carinii in a cohort of normal, healthy infants Clin Infect Diseases: Official Publication Infect Dis Soc Am 32 855-2